<DOC>
	<DOCNO>NCT00635206</DOCNO>
	<brief_summary>The primary objective outcome proportion participant compliant ( least four hour use per night night ) Auto Bilevel group compare CPAP group 90 day treatment investigation . Proportion calculate use cumulative number hour therapy divide total number day investigation participant . The mean standard deviation mean therapy hour calculate arm investigation . Participants compliance least four hour classify `` compliant '' le four hour classify `` non-compliant '' . The null hypothesis reject mean primary objective outcome participant BiPAP® Auto Bi-Flex® therapy arm significantly great participant CPAP therapy arm . Secondary Measures The secondary measure use evaluate potentially improve adherence BiPAP® Auto Bi-Flex® therapy compare CPAP therapy include : - Hours use per night , night - Hours use per night , night therapy use - Device derive AHI - Heart Rate Variability - Functional Outcomes Sleep Questionnaire ( FOSQ ) , - 10 cm Visual Analog Scale ( VAS ) mask comfort satisfaction therapy , - Epworth Sleepiness Scale ( ESS ) questionnaire - Psychomotor Vigilance Task - Attitudes toward use - Actigraphy ( sleep continuity ) sleep diary - Fatigue Severity Scale - Daytime Functioning Scale</brief_summary>
	<brief_title>Investigation Novel Positive Pressure Therapy Rescue Patients Failing Tolerate CPAP During Initial Encounter</brief_title>
	<detailed_description>The hypothesis investigation BiPAP® Auto Bi-Flex® improve acceptance adherence positive pressure therapy participant newly diagnose OSA meet objective criterion PAP failure initial encounter CPAP sleep laboratory . This hypothesis test use two-arm , randomize , double-blind design . Participants fail tolerate CPAP therapy sleep laboratory titration night randomize BiPAP® Auto Bi-Flex® titration CPAP titration night lab . Participants go home respective therapy three month .</detailed_description>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Inclusion Criterion : 1 . Age 2175 2 . New Diagnosis OSA baseline RDI ≥ 15 events/hr sleep determine either full night split night PSG 3 . Able willing provide write informed consent 4 . Able follow study procedure 5 . Suboptimal PSG titration least 3 hour attempt PAP titration ( define ) : deem physician titration failure Suboptimal PSG titration : least one following : 1 . Poor sleep efficiency titration period ( sleep efficiency ≤ 70 % ) ( participant may sleep medication per standard lab CPAP protocol ) ; 2 . Frequent arousal base three second alpha frequency EEG ( non PLMrelated ) 20 great per hour titration portion study ; 3 . CPAP titration abort due participant 's request ( due intolerance ) , 4 . Persistent sleep disruption despite therapeutic CPAP therapy judgment review physician , suggest low probability CPAP adherence Exclusion Criterion : 1 . Participation another interventional research study within last 30 day 2 . Major uncontrolled medical psychiatric condition congestive heart failure , neuromuscular disease , renal failure etc . 3 . Prior CPAP BiLevel PAP use ( within last 2 year ) 4 . Chronic respiratory failure insufficiency , moderate COPD ( FEV1 &lt; 60 % ) , know condition elevation arterial carbon dioxide level awake 5 . Surgery upper airway , nose , sinus , middle ear within previous 90 day 6 . Presence untreated , diagnosable , nonOSA related sleep disorder ( e.g . restless legs syndrome , insomnia , etc . ) 7 . Periodic Limb movement arousal index 10 great . 8 . Refusal consider intervention standard CPAP optimize positive pressure therapy ( e.g . different mask use lab ) 9 . PAP therapy otherwise medically complicate contraindicate difficult size adjust interface ( mask ) result facial pain , skin irritation trauma , excessive air leak 10 . Shift worker people experience jet lag 11 . Known history alcohol drug abuse 12 . Diagnosis Complex Sleep Apnea , ( appear classic obstructive mixed sleep apnea , exhibit disruptive central apnea periodic breathe CPAP ) 11 , 12 persistent central apnea diagnostic PSG . 13 . Diagnosis Attention Deficit Hyperactivity Disorder 14 . Chronic Hypnotic use ( nightly use three month less )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>OSA</keyword>
</DOC>